BusinessAI drug developer Pathos AI raises $237 million Series E at $3 billion valuationOct 23, 4:34 PM • 3 min read
BusinessAstraZeneca signs AI drug discovery deal with Insitro worth up to $1.5 billionOct 15, 6:04 PM • 2 min read
BusinessByteDance's AI drugmaking spinout Anew Labs raises $290 million at $1.5 billion valuation: ReutersSep 16, 7:46 PM